- Research article
- Open Access
The collagen structure of C1q induces wound healing by engaging discoidin domain receptor 2
Molecular Medicine volume 27, Article number: 125 (2021)
C1q has been reported to reveal complement-independent roles in immune and non-immune cells. C1q binds to its specific receptors to regulate distinct functions that rely on the environment and cell types. Discoidin domain receptor 2 (DDR2) is activated by collagen and functions in wound healing by controlling matrix metalloproteinase (MMP) expression. Since C1q exhibits a collagen-like structure, we hypothesized that C1q might engage DDR2 to regulate wound healing and extracellular matrix (ECM) remodeling.
Cell-based assay, proximity ligation assay, ELISA, and surface plasmon analysis were utilized to investigate DDR2 and C1q binding. We also investigate the C1q-mediated in vitro wound healing ability using the human fibrosarcoma cell line, HT1080.
C1q induced the phosphorylation of DDR2, p38 kinase, and ERK1/2. C1q and DDR2 binding improved cell migration and induced MMP2 and MMP9 expression. DDR2-specific shRNA reduced C1q-mediated cell migration for wound healing.
C1q is a new DDR2 ligand that promotes wound healing. These findings have therapeutic implications in wound healing-related diseases.
Wound healing remains a clinical challenge, and efficient wound management is important for preventing chronic wounds. Wound healing integrates various resident and migratory cells, the extracellular matrix, growth factors, and cytokines involved in the inflammation, proliferation, and remodeling phases (Velnar et al. 2009). This complex process involving migration, proliferation, interaction, and differentiation of epidermal or dermal cells, biomolecular interactions, synthesis of matrix components occur in the injured tissue to restore wound healing (Masson-Meyers et al. 2020; Thomas 2011). Epithelial cells play a crucial role during the wound healing process by proliferating and migrating toward the injured area (Leoni et al. 2015; Landen et al. 2016). Chronic diseases such as obesity or diabetes delay wound healing, and the studies of wound assessment strategies will benefit wounded patients (Masson-Meyers et al. 2020).
C1q is the first complement component. It serves as a recognition signal that triggers the classical pathway and induces the clearance of apoptotic cells and immune complexes (Thielens et al. 2017; Trinder et al. 1996; Nayak et al. 2010). C1q consists of six trimeric globular heads (gC1q) and a collagen-like tail with Gly-Pro-Hyp collagen-like sequence repeats (cC1q) (Reid 1974). C1q in human serum binds with danger-associated molecular patterns (DAMPs) released from apoptotic and necrotic cells, including phosphatidylserine, nucleic acids, and HMGB1 (Lee et al. 2018; Son et al. 2016; Kim et al. 2018). In response to infection, C1q also binds to pathogen-associated molecular patterns (PAMPs), including lipopolysaccharides. With these features, C1q is anchored to the membrane and functions in phagocytosis, angiogenesis, apoptosis, and cytokine or chemokine induction, which are important for modulating the inflammatory response (Kishore et al. 2004; Ghebrehiwet et al. 2017). Privileged engagement of distinct C1q (gC1q vs. cC1q) regions occurs during different stages of immune cell activation and function (Thielens et al. 2017; Nayak et al. 2010). The diversity of C1q functions is related in part to its domain and depends on each receptor. There are several C1q receptors on the cell surface: (1) gC1q receptors, including the receptor for advanced glycation end products (RAGE), Siglec-3, CD91, CD33, and dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN); and (2) cC1q receptors, including calreticulin and leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) (Thielens et al. 2017; Son et al. 2015; Son et al. 2012; Son et al. 2017). cC1q exhibits structural similarities with collagen VIII and X and the collagen receptors α2β1, LAIR-1, and DDR1 have been reported to be C1q receptors (Lee et al. 2018; Son et al. 2015).
Although several studies have elucidated the role of C1q in non-hematopoietic cells, the physiological receptor for C1q in non-hematopoietic cells and the mechanism of C1q in the wound healing process remain unclear. C1q is expressed by invading trophoblast and endothelial cells and contributes to vascular and tissue remodeling (Agostinis et al. 2016). C1q is highly expressed in the stroma and vascular endothelium in tumor microenvironments; therefore, it can serve as a cancer-promoting factor (Bulla et al. 2016). C1q also enhances endothelial cell proliferation and migration, tube formation, and angiogenesis (Ghebrehiwet and Peerschke 2004; Bossi et al. 2014; Feng et al. 2002).
Discoidin domain receptors (DDRs), including DDR1 and DDR2, are classified as receptor tyrosine kinases (RTKs) based on the presence of a catalytic kinase domain (Shrivastava et al. 1997). DDRs are activated by fibrillar and non-fibrillar collagens, which are the major components of all types of extracellular matrix (ECM), thus playing a role in the regulation of collagen–cell interactions (Marquez and Olaso 2014; Vogel et al. 1997). ECM remodeling is associated with matrix metalloproteinase (MMP) production, which is important in re-epithelialization (Marquez and Olaso 2014) as it allows for cell migration and tissue remodeling (Caley et al. 2015). Abnormalities in the healing process and dysregulation of MMPs lead to prolonged inflammation and chronic wounds. DDR2 is activated by fibrillar collagen, specifically collagen type I (Vogel et al. 1997). The catalytic tyrosine kinase domain of DDR2 undergoes phosphorylation following fibrillar collagen binding (Vogel et al. 1997). Unlike other RTKs, DDR2 phosphorylation occurs long after ligand binding and is sustained for over 24 h (Iwai et al. 2013). DDR2 is well-known for its function in wound healing. DDR2−/− mice showed delayed closure of dermal wounds (Olaso et al. 2011). Furthermore, DDR2 is required for proliferative response during skin wound healing (Labrador et al. 2001).
Fibroblasts in human acute wounds express MMP2 and endothelial cells to accelerate cell migration (Giannelli et al. 1997). Likewise, MMP9 is expressed in several injured epithelia to promote wound healing (Mohan et al. 2002). Types I, II, III, IV, and V collagens activate DDR1, while types I, II, III, and X collagens stimulate DDR2 (Shrivastava et al. 1997; Leitinger 2011). Human DDR1 and DDR2 exhibit about 50% sequence homology and have a discoidin-homology domain (DD), a discoidin-like domain (DLD), an extracellular juxtamembrane domain, a transmembrane domain, a cytosolic domain, and a tyrosine kinase domain. Collagen binding to the DD induces receptor autophosphorylation (Leitinger 2003).
DDR2 signaling is required for normal bone development and wound healing, while DDR1 signaling is required for normal skeletal development, mammary gland branching morphogenesis, and blastocyst implantation (Marquez and Olaso 2014; Olaso et al. 2011; Borza and Pozzi 2014; Page-McCaw et al. 2007; Yan et al. 2014). DDR2 is also upregulated in dermal burn wounds (Feezor et al. 2004). Moreover, DDR2-deficient mice exhibit impaired dermal wound healing due to reduced fibroblast proliferation and reduced bone growth as a result of reduced chondrocyte proliferation (Olaso et al. 2011; Olaso et al. 2002).
Considering that C1q and DDRs play roles in wound healing and C1q exhibits a collagen-like structure, we hypothesized that C1q might engage with DDR2 to regulate wound healing. Here, we examined the direct binding of DDR2 and C1q and, for the first time, demonstrated the C1q-mediated DDR2 autophosphorylation and in vitro C1q-mediated wound healing ability of epithelial cells. The results would help in understanding how C1q affects the epithelial cells, and the engagement of DDR2 may contribute to the development of successful treatments to enhance wound healing.
Cell line and culture
The human fibrosarcoma cell line, HT1080 (ATCC CCL-121; ATCC, Manassas, VA, USA), which is epithelial-like and originated from connective tissue and preferentially expresses DDR2 mRNA and protein over DDR1 (Saby et al. 2016), was used. HT1080 cells were maintained in Minimum Essential Medium (Wellgene, Korea and Thermo Fisher Scientific, MA, USA) containing 10% fetal bovine serum and 1% penicillin–streptomycin (Wellgene and Thermo Fisher Scientific). Cell cultures were maintained at 37 °C in the humidified atmosphere of a 5% CO2 incubator.
Analysis of C1q binding to DDR2 using enzyme-linked immunosorbent assay (ELISA)
Recombinant human DDR2 possessing the ectodomain of DDR2 (Gln24-Arg399) with 6 × His-tag on C-terminal (sDDR) was purchased (2538-DR; R&D Systems, Minneapolis, MN, USA). For the assay, 2 and 8 μg/mL of collagen-I (C7774; Sigma-Aldrich, Darmstadt, Germany), 2 μg/mL human C1q protein (C1740; Sigma-Aldrich), and sDDR2 were coated on ELISA plates (Corning, NY, USA) and incubated at 4 °C overnight. Bovine serum albumin (BSA; Sigma-Aldrich) was also coated as a negative control protein. The plates were washed twice with Dulbecco’s phosphate-buffered saline (DPBS; Wellgene) and blocked with 200 μL of 3% BSA at 25 °C for 1 h. Various concentrations (0.1, 0.5, 2, and 8 μg/mL) of sDDR2 or C1q were added to the wells and incubated at 37 °C for 2 h. After washing, mouse anti-DDR2 (MAB2538; R&D Systems) or rabbit anti-C1q antibody (Ab) (A0136; Dako Denmark A/S, Glostrup, Denmark) was added in 3% BSA at RT for 1 h. Horseradish peroxidase (HRP)-conjugated goat anti-mouse Ab (31430; Life Technologies, Inc., Gaithersburg, MD, USA) or goat anti-rabbit Ab (31460; Life Technologies) was used as the secondary Ab. 3,3′,5,5′-Tetramethylbenzidine (TMB) solution was added for color development, and the optical density of each well was measured at 450 nm. Non-coated blank well values were subtracted, and normalized values were subjected to statistical analysis.
Analysis of C1qA peptide binding to DDR2 using ELISA
C1qA peptide (Biotin-GSKGEQGEPGAPGI, GenScript, Piscataway, NJ, USA), control peptide (Biotin-KAEQAEPAAPAI, GenScript), sDDR (2538-DR; R&D Systems), or BSA (Roche, Basel, Switzerland) were coated on an ELISA plate (Corning) at 8 μg/mL in PBS and incubated overnight at 4 °C. The plates were washed with 0.05% PBS with Tween-20 (PBST) twice and blocked with 1% BSA fraction V (Roche) in PBS at 25 °C for 1 h. Various concentrations of sDDR2 (0.1, 0.5, 2, or 8 μg/mL) or C1qA peptide (0.1, 0.5, 2, or 8 μg/mL) were added and incubated at RT for 2 h. After washing with 0.05% PBST, alkaline phosphatase (AP)-conjugated anti-6x-His Ab (3D5, Invitrogen, Waltham, MA, USA) for sDDR2 detection or AP-conjugated streptavidin (7105–04, Southern Biotech, Birmingham, AL, USA) for C1qA peptide or control peptide were incubated at RT for 1 h. Phosphatase substrate (S0942, Sigma-Aldrich) solution was added for color development, and the optical density of each well was measured at 405 nm.
Surface plasmon resonance (SPR) analysis
SPR (Biacore 3000, GE Healthcare, Chicago, IL, USA) analysis was used to detect the interaction of sDDR2 with C1q proteins. With the scouted buffer conditions (10 mM sodium acetate, pH 4.0–6.0), sDDR2 protein was immobilized on the surface of the sensor chip CM5 (GE Healthcare). To derive the ligand values, a coupling process was performed based on the molecular weights of sDDR2 (MWligand) and C1q (MWanalyte). Samples were injected into running buffer consisting of 10 mM HEPES (pH 7.4) at 25 °C (10 μL/min flow rate). Sensorgrams were recorded and analyzed in real time using the Biacore 3000 control software. Six concentrations of C1q proteins (0, 2.5, 5, 10, 20, and 40 μg/mL) were used for binding to derive the KD values. All exercise data were calculated using BIAevaluation Software (GE Healthcare).
sDDR2 and C1q proteins were incubated at 37 °C for 2 h. Complete His-Tag Purification Resin (5893682001; Roche Diagnostics GmbH, Mannheim, Germany) was blocked with 3% BSA (Sigma-Aldrich) at 4 °C for 1 h. The resin was mixed with the proteins and rotated on a shaker at 4 °C overnight. After washing with 0.1% PBST, pull-down samples were subjected to sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) and western blot to detect the proteins using mouse anti-DDR2 (R&D Systems) and rabbit anti-C1q Ab (Dako). For C1qA peptide and DDR2 binding assay, biotinylated-C1qA peptide (20 μg/mL) was precoated on streptavidin-conjugated microbeads (SpeedBeads™, Thermo Fisher Scientific). Beads were incubated with sDDR2 (1 or 5 μg) at 4 °C for 2 h. After extensive washing, DDR2 and C1qA peptide were visualized using western blot and dot blot with antibodies for His tag (for DDR2) or infrared 800-labeled streptavidin (for biotinylated C1qA peptide). The signals were detected by the Sapphire™ Biomolecular Imager (Azure Biosystems, Dublin, CA, USA).
HT1080 cells were seeded in 6-well plates at a density of 5 × 105 cells/mL, harvested and washed twice with DPBS, and then centrifuged at 6000 rpm for 10 min. Next, the cells were fixed with 4% paraformaldehyde at RT for 30 min and washed with DPBS twice. The fixed cells were stained with or without rabbit anti-DDR2 Ab (sc-8989; Santa Cruz Biotechnology, Dallas, TX, USA) and goat anti-rabbit Ab conjugated with Alexa Fluor 488 (A11008, Invitrogen, OR, USA) at 4 °C in the dark for 1 h. Human IgG Fc at the same concentration was used as the control. Cells were washed with DPBS and all stained cell samples were analyzed via flow cytometry using the FACSVerse system (BD Biosciences, San Jose, CA, USA).
HT1080 cells were seeded in 4-well chamber slides at a density of 1.5 × 105 cells/well, fixed in 4% paraformaldehyde for 30 min on ice, and then washed thrice on ice with DPBS. Cells were blocked with 3% BSA for 30 min, stained with or without mouse anti-DDR2 Ab (R&D Systems) at 4 °C overnight, and then incubated with Alexa Fluor 488-conjugated goat anti-mouse Ab (A32723, Invitrogen) for 45 min in the dark. The nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI) and cells were observed with a FluoView FV1000 confocal microscope (Olympus, Tokyo, Japan).
For C1q binding assay, HT1080 cells were cultured and incubated with 2 μg/mL C1q in a serum-free medium for 2 h. sDDR2 (2 μg/mL) was also co-incubated to observe the inhibition of C1q and cell surface DDR2 binding. After treatment, the cells were washed, fixed, and blocked as described above. The cells were then stained with or without mouse anti-DDR2 Ab (R&D Systems) and with or without rabbit anti-C1q Ab (Dako) at 4 °C overnight. After they were washed thrice, the cells were incubated with Alexa Fluor 488-conjugated goat anti-rabbit Ab (A11008, Invitrogen) for C1q or Alexa Fluor 594-conjugated goat anti-mouse Ab for DDR2 (A32742, Invitrogen) for 45 min in the dark, and then mounted and examined using confocal microscopy. To determine the percentage colocalization of both proteins, images were loaded onto Image J software (NIH, Rockville, MD, USA) and the ratios of green or red to merged cells were measured using the colocalization plug-in.
Proximity ligation assay
Proximity ligation assay (PLA) was performed according to the manufacturer’s protocol (Duolink®, Sigma-Aldrich). Cells were washed with cold DPBS, fixed with 4% paraformaldehyde for 30 min on ice, blocked with 3% BSA for 30 min, and then stained with or without mouse anti-DDR2 Ab (R&D Systems) and with or without rabbit anti-C1q Ab (Dako) at 4 °C overnight. The cells were incubated with the corresponding PLA probes conjugated to oligonucleotides (mouse MINUS and rabbit PLUS), followed by ligation and rolling circle amplification in proximity. The nuclei were stained with DAPI, and cells were observed using FluoView FV1000 confocal microscope. Interactions were quantified by counting the number of dots per cell using Image J software.
Western blotting and immunoprecipitation
HT1080 cells were stimulated with 20 μg/mL of collagen-I, C1q (A099, Complement Technologies, Tyler, TX, USA) or C1qA peptide (Biotin-GSKGEQGEPGAPGI, GenScript) for the indicated time points. Cells were lysed in RIPA cell lysis buffer containing protease and phosphatase inhibitors (GenDEPOT Inc., Katy, TX, USA) to obtain protein extracts. Protein concentration was determined using the BCA protein assay kit (Pierce Biotech, Rockford, IL, USA). The following primary antibodies were used: mouse anti-DDR2 (MAB2538; R&D Systems), rabbit anti-DDR2 (12133; Cell Signaling Technology, Danvers, MA, USA), rabbit anti-C1q (A0136; Dako), rabbit anti-pp38 (9211S; Cell Signaling Technology), rabbit anti-p38 (9212; Cell Signaling Technology), rabbit anti-pERK1/2 (9101; Cell Signaling Technology), rabbit anti-ERK1/2 (9102; Cell Signaling Technology), and rabbit anti-β-actin (4967; Cell Signaling Technology) Abs. For western blotting, equal amounts of protein or immunoprecipitated proteins in protein sample buffer (100 mM Tris–HCl at pH 6.8, 2% SDS, 25% glycerol, 0.1% bromophenol blue, and 5% β-mercaptoethanol) were resolved by 8 or 12% SDS-PAGE and transferred to nitrocellulose membranes (Amersham Biosciences, Buckinghamshire, UK). After blocking in tris-buffered saline containing 5% skim milk and 0.1% Tween-20, the membranes were incubated with primary antibodies, followed by incubation with HRP-labeled secondary antibodies. West-Q Pico ECL solution (GenDEPOT Inc.) was used to develop the images.
To observe DDR2 phosphorylation, phosphotyrosine immunoblot was performed after DDR2 immunoprecipitation using rabbit anti-DDR2 Ab (12133; Cell Signaling Technology) at 4 °C overnight. Pre-equilibrated Dynabeads-conjugated protein G (10003D; Invitrogen) was incubated with the Ab at 4 °C for 1 h. Samples were subsequently immunoblotted by mouse anti-phosphotyrosine Ab (4G10; MP-05–321; Millipore, Burlington, MA, USA) after washing for western blotting.
In vitro cell wound healing assay
HT1080 cells were grown to confluence in 12-well plates (Corning) and a straight scratch was made in each well using a 1 mL-pipette tip. The cells were then washed with DPBS twice and further cultured with collagen-I (20 μg/mL) or C1q (20 μg/mL) for the indicated time. The gap of the scratch was recorded using an Olympus IX73 inverted microscope (Olympus).
CytoSelectTM Wound Healing Assay Kit (HT1080 cells (Cell Biolabs, San Diego, CA, USA) was used (Fig. 5E and F). Briefly, HT1080 cells (3 × 105 per well) were cultured in a 24-well plate until they form a monolayer around the insert that could generate a defined wound field or gap. Cells were treated with C1q (20 μg/mL; A099, Complement Technologies), C1qA peptide (200 nM) or sDDR2 (2 μg/mL; R&D Systems) in serum free X-VIVO media (Lonza, GA, USA). The wound field surface area was visualized via phase contrast or DAPI fluorescence labeling. Images were taken in three different areas per well using an Evos M7000 microscope (Thermo Fisher Scientific) at the indicated time points. The wound closure area was determined at each time point from the digital images using Image J and the wound healing rate was calculated as the (covered wound area/total surface area) × 100.
Short hairpin RNA and transfection assay
DDR2 knockdown was achieved using stable short hairpin interfering RNAs (shRNAs). To target DDR2 (NM_006182 NCBI), we used #TRCN0000001418 (Yonsei Genomics Center System Biology Core, Seoul, Korea). #SHC016 was also used as scramble sequence shRNA. HT1080 cells were transfected using Fugene HD transfection reagent (Roche Diagnostics) according to the manufacturers’ instruction for 36 h. The knockdown efficiency was determined by western blotting using rabbit anti-DDR2 Ab (12133; Cell Signaling Technology). DDR2 knockdown HT1080 cells were subsequently plated on 12-well plates 48 h after transfection and incubated overnight. The wound healing assay was performed up to 72 h after transfection.
HT1080 cells were treated with collagen-I or C1q (20 μg/mL) in serum-free medium, then harvested, briefly centrifuged, and immediately frozen at − 20 °C to prevent auto-activation of MMPs. Aliquots of medium were later prepared in native buffer. Proteins were resolved by 8% polyacrylamide gels containing 0.1% gelatin without boiling. Gels were incubated in 1 × Zymogram Renaturation Buffer (Bio-Rad, Hercules, CA, USA) for 30 min, washed with distilled water, and incubated in 1 × Zymogram Development Buffer (Bio-Rad) for 30 min. Then, the gels were incubated in fresh 1 × Zymogram Development Buffer overnight at 37 °C and later stained with 0.5% Coomassie brilliant blue in 10% acetic acid and 50% methanol. The gels were destained with 50% methanol and 10% acetic acid and observed using a MiniBIS Pro imager (DNR Bio-Imaging Systems Ltd., Neve Yamin, Israel).
Dot blot assay
Recombinant proteins (20 μg per spot), such as NS0-derived recombinant mouse DDR2-Fc chimera protein (7479-DR, R&D Systems), DDR1-Fc (6416-DR, R&D System) or Fc (4460-MG, R&D Systems) were blotted onto a nitrocellulose membrane. Both the DDR2 ectodomain (Gln24-Arg399) and DDR1 ectodomain (Met1-Thr414) fused with Mouse IgG2A (Glu98-Lys330) at the C-terminal. The membrane was dried and blocked with 5% skim milk in PBS at RT for 1 h. Biotinylated C1qA peptide (200 nM) in 3% skim milk were incubated at RT for 2 h. The blots were washed thrice in 0.05% PBST and incubated with InfraRed 680 conjugated-streptavidin for 1 h. The signals were detected by the Sapphire™ Biomolecular Imager (Azure Biosystems, CA, USA).
Quantitative real time-PCR
Total RNA was extracted from cells with an RNeasy kit (Qiagen), and cDNA was generated using an iScript cDNA synthesis kit (Bio-Rad). Real Time-PCR reactions were performed on a Light Cycler 480 II (Roche) using Light Cycler 480 Probes Master (Roche). Primers for MMP9 (Hs00957562) and HPRT1 (Hs02800695) were purchased from Thermo Fisher Scientific. The genes of interest were normalized to the housekeeping gene, HPRT1, and 2−ΔCt was used to calculate the relative expression. Relative fold increase was analyzed using the 2−ΔΔCt method compared to untreated control.
Results were presented as the mean ± standard error of the mean (SEM) mentioned in each figure legend. Data were analyzed using IBM SPSS Statistics version 22.0 (IBM Corp., Armonk, NY, USA) and GraphPad Prism 9 (GraphPad Software, San Diego, CA, USA). Comparisons between more than three groups were analyzed via one-way ANOVA and the Student’s t test was used to compare the means between two groups. A p value < 0.05 was considered statistically significant.
Binding between C1q and DDR2
DDR2 binding to C1q was examined using ELISA. As binding of collagen-I with DDR2 is well known, we tested this binding as the experiment for positive control. Microtiter wells were coated with 2 μg/mL collagen-I and BSA, and various concentrations of sDDR2 protein were added. As expected, sDDR2 bound with collagen-I in a concentration-dependent manner, while it did not bind with BSA (Fig. 1A). Next, the binding of sDDR2 with C1q was tested. sDDR2 protein was added to the microwells coated with C1q at 8 μg/mL. As shown in Fig. 1B, sDDR2 bound with C1q in a concentration-dependent manner but did not bind with BSA. In the reverse experiment, C1q was added to microtiter plates coated with 2 μg/mL sDDR2. C1q bound with sDDR2 in a concentration-dependent manner but did not bind with BSA (Fig. 1C). Next, we performed an immunoprecipitation assay to confirm the interaction between C1q and DDR2. Equal concentrations (100 ng/mL) of C1q and sDDR2 protein tagged with 6 × His were mixed and pull-down assay was conducted with His-tag-sensitive resin. C1q protein bound to sDDR2 was observed using western blotting. Two clear C1q bands (29 and 27 kDa) were observed when both proteins were present (Fig. 1D). Moreover, SPR showed the interaction of C1q with sDDR2 immobilized on the CM5 chip in a concentration-dependent manner. KD value is 1.83 × 10–7 M, indicating that C1q has a high binding affinity for sDDR2 (Fig. 1E).
C1q binds to DDR2 expressed by HT1080 cells
We observed DDR2 expression in the HT1080 epithelial cell line via confocal microscopy and flow cytometry (Fig. 2A). Next, we tested whether C1q binds to DDR2-expressing HT1080 cells by adding 2 μg/mL C1q protein to the cultures for 2 h. Then, C1q (green) and DDR2 (red) were detected using specific antibodies and the merged images were observed via confocal microscopy. C1q and DDR2 were colocalized on the HT1080 cell surface (Fig. 2B). The specificities of these interactions were further demonstrated through blocking experiments. The colocalization of C1q and DDR2 was reduced in the presence of 2 μg/mL sDDR2, confirming that C1q can bind with DDR2 (Fig. 2B). Similar results were observed in the PLA. Polymerase-amplified fluorescence showed C1q-DDR2 colocalization, and the addition of sDDR2 inhibited the C1q-DDR2 proximity (Fig. 2C).
C1q promotes wound healing by binding with DDR2
To determine whether C1q mediates DDR2 phosphorylation, HT1080 cells were stimulated with several concentrations of C1q and collagen-I for 24 h. Then, DDR2 phosphorylation was determined via immunoprecipitation with anti-DDR2 Ab followed by immunoblot analysis for phosphotyrosine. While collagen-I phosphorylated DDR2 in a dose-dependent manner, 20 μg/mL of C1q drastically increased DDR2 phosphorylation in HT1080 cells at 24 h (Fig. 3A).
Confluent monolayers of HT1080 cells were wounded with a uniform scratch and washed to remove debris. The cells were incubated in the absence or presence of C1q for a specific duration and the wound healing rate was measured accordingly. Wound closure increased significantly with 20 μg/mL C1q treatment in a time-dependent manner (Fig. 3B).
To determine the significant role of DDR2 in C1q wound healing, DDR2 was transiently knocked down using shRNAs in the HT1080 cell line. DDR2 expression was ~ 70% downregulated by shRNA transfection at 36 h after transfection (Fig. 3C). Subsequently, DDR2 shRNA or scrambled control RNA-transfected HT1080 cells were further assessed using an in vitro scratch test for up to 72 h after transfection. C1q-induced cell migration decreased in DDR2 shRNA-transfected cells by ~ 23% compared to control cells (Fig. 3D). These data suggest that C1q-DDR2 binding induces cell migration.
C1q induces MMP2 and MMP9 expression via p38 and ERK1/2 pathways
MMP2 and MMP9 productions were tested by C1q stimulation at 20 μg/mL in HT1080 cells. Gelatin zymography showed that active MMP2 and MMP9 expression were significantly induced by C1q treatment similar to collagen-I treatment in a time-dependent manner (Fig. 4A–C). Furthermore, we investigated the phosphorylation status of p38 and ERK1/2 in HT1080 cells at different time points following treatment with 20 μg/mL collagen-I and C1q to assess the related signaling pathways (Fig. 4D–F). C1q significantly increased p38 and ERK1/2 phosphorylation in a time-dependent manner for 24 h after treatment. Moreover, DDR2 phosphorylation was also continuously increased for 24 h, demonstrating that C1q is a novel functional ligand of DDR2 (Fig. 4D).
The C1q collagen region is the DDR2 binding site
To confirm that the C1q collagen structure is a critical region for DDR2 binding, we tested whether DDR2 binds with a synthetic C1q collagen tail peptide (C1qA peptide) that is known to bind with LAIR-1 (Liu et al. 2019). We found that it binds both DDR2 and DDR1 (Fig. 5A). C1qA bound to sDDR2 in a concentration-dependent manner according to the results of ELISA (Fig. 5B and C) and pull-down assay (Fig. 5D). Furthermore, C1qA peptide promotes wound healing (Fig. 5E). The enhanced wound healing effect of C1q and C1qA peptide was diminished by sDDR2 (Fig. 5F). To observe the direct effect of C1qA peptide on DDR2 activation, we tested whether C1qA peptide can cause the autophosphorylation of DDR2. C1qA peptide induced DDR2 phosphorylation after 24 h of stimulation (Fig. 5G) and enhanced the expression of MMP-9 (Fig. 5H).
A complete understanding of the phases of the healing process is essential for recognizing factors that may complicate or delay wound healing (Thomas 2011). ECM remodeling is important in re-epithelialization and is associated with MMP production. Fibroblasts in acute human wounds express MMP2, and MMP9 is expressed in several injured epithelia to promote wound healing (Marquez and Olaso 2014). Studies have indicated the correlation between p38 kinase and ERK1/2 pathways with MMP2 and MMP9 activity (Yu and Kim 2016; Gweon and Kim 2013). This study shows for the first time that DDR2 is the receptor for C1q that is involved in wound healing and is present on the surface of epithelial cells. C1q and DDR2 binding improved cell migration and induced MMP2 and MMP9 expression in HT1080 epithelial cells.
Our previous data showed that C1q binds to DDR1 and promotes hepatocellular tumor progression (Lee et al. 2018). Although both DDRs are similar, they have distinct functions, expression profiles, and sequential roles in inflammation response, depending on the microenvironment and cell types (Afonso et al. 2013). DDR1 expression is increased in the glomeruli of patients with lupus nephritis (Kerroch et al. 2012). DDR2 expression increases in the cartilage of patients with osteoarthritis and correlates with the degree of cartilage damage in human knee joints (Sunk et al. 2007). Therefore, their functional differences might be related to their expression profiles and location (Abbonante et al. 2013). Moreover, other collagen-like structures containing molecules such as surfactant proteins or adiponectin may also be potential DDR ligands (Haczku 2008; Sun et al. 2016).
While C1q regulates non-hematopoietic cells such as epithelial cells, C1q also involves macrophage differentiation (Son et al. 2016; Bohlson et al. 2014). Thus, C1q may modulate infiltrated hematopoietic cells by engaging its receptors in a time-dependent manner in the wound tissue. Since C1q activates phosphoinositide 3 kinase/Akt signaling directly to DDR1 (Lee et al. 2018), PI3K/AKT might be upstream of ERK1/2 and p38. The level of C1q is increased with age and delays wound healing by modulating Wnt signaling (Naito et al. 2012). During acute wound healing, pro-inflammatory macrophages infiltrate the wound site after injury to clean the wound of microorganisms and apoptotic debris. As the tissue resolves inflammation, the overall macrophage population transitions to anti-inflammatory macrophages (Aonuma et al. 2021). Additionally, C1q could bind with the DAMP molecule HMGB1, which is secreted under proinflammatory oxidative conditions. Further study is necessary to clarify the effect of wound healing process of both molecules interacting with DDR2 (Kim et al. 2018; Kwak 2019). Thus, C1q may perform multiple functions in complicated wound regions by engaging its receptors.
Collagen peptides and LAIR-1 ligand peptides have been developed to promote cell-specific receptor functions (Liu et al. 2019; Son and Diamond 2015). According to this study, the impact of the C1qA peptide may not be limited to LAIR-1 on hematopoietic cells. DDR2 is well known to bind to the triple-helical form of collagen, and not to denatured collagen or collagen-mimetic peptides that are not triple-helical form (Carafoli et al. 2009; Konitsiotis et al. 2008). Further investigation is necessary how C1qA peptide, which does not appear to be triple-helical, bind DDR2. Our findings are potentially applicable in repurposing opportunities for treating inflammation and promoting wound healing. The present in vitro study would be helpful in preclinical models for wound healing studies (Caetano et al. 2015; Pegorin et al. 2021). Further understanding of physiological C1q binding to DDR2 is necessary for therapeutic applications in wound healing-related diseases.
This work uncovers the interaction of C1q and DDR2, which promotes wound healing and possibly angiogenesis. C1q and DDR2 binding improved cell migration and induced MMP2 and MMP9 expression involved in wound healing in vitro.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Discoidin domain receptor
Receptor tyrosine kinase
C1q globular heads
C1q collagen tail
Danger-associated molecular patterns
Pathogen-associated molecular patterns
Pathogen recognition receptor
Leukocyte-associated Ig-like receptor-1
Proximity ligation assay
Receptor for advanced glycation end products
Abbonante V, et al. Discoidin domain receptor 1 protein is a novel modulator of megakaryocyte-collagen interactions. J Biol Chem. 2013;288:16738–46.
Afonso PV, McCann CP, Kapnick SM, Parent CA. Discoidin domain receptor 2 regulates neutrophil chemotaxis in 3D collagen matrices. Blood. 2013;121:1644–50.
Agostinis C, et al. Complement component C1q as potential diagnostic but not predictive marker of preeclampsia. Am J Reprod Immunol. 2016;76:475–81.
Aonuma F, et al. Effect of aging on bone metabolism: the involvement of complement C1q. J Prosthodont Res. 2021;65:393–9.
Bohlson SS, O’Conner SD, Hulsebus HJ, Ho MM, Fraser DA. Complement, c1q, and c1q-related molecules regulate macrophage polarization. Front Immunol. 2014;5:402.
Borza CM, Pozzi A. Discoidin domain receptors in disease. Matrix Biol. 2014;34:185–92.
Bossi F, et al. C1q as a unique player in angiogenesis with therapeutic implication in wound healing. Proc Natl Acad Sci U S A. 2014;111:4209–14.
Bulla R, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346.
Caetano GF, et al. Chitosan-alginate membranes accelerate wound healing. J Biomed Mater Res B Appl Biomater. 2015;103:1013–22.
Caley MP, Martins VL, O’Toole EA. Metalloproteinases and wound healing. Adv Wound Care (New Rochelle). 2015;4:225–34.
Carafoli F, et al. Crystallographic insight into collagen recognition by discoidin domain receptor 2. Structure. 2009;17:1573–81.
Feezor RJ, et al. Temporal patterns of gene expression in murine cutaneous burn wound healing. Physiol Genomics. 2004;16:341–8.
Feng X, Tonnesen MG, Peerschke EI, Ghebrehiwet B. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol. 2002;168:2441–8.
Ghebrehiwet B, Peerschke EI. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol. 2004;41:173–83.
Ghebrehiwet B, Hosszu KH, Peerschke EI. C1q as an autocrine and paracrine regulator of cellular functions. Mol Immunol. 2017;84:26–33.
Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 1997;277:225–8.
Gweon EJ, Kim SJ. Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells. Oncol Rep. 2013;29:826–34.
Haczku A. Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. J Allergy Clin Immunol. 2008;122:861–79 (quiz 880–861).
Iwai LK, et al. Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants. Biochem J. 2013;454:501–13.
Kerroch M, et al. Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. FASEB J. 2012;26:4079–91.
Kim SY, et al. High-mobility group box 1-induced complement activation causes sterile inflammation. Front Immunol. 2018;9:705.
Kishore U, et al. Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett. 2004;95:113–28.
Konitsiotis AD, et al. Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen. J Biol Chem. 2008;283:6861–8.
Kwak MS, et al. Peroxiredoxin-mediated disulfide bond formation is required for nucleocytoplasmic translocation and secretion of HMGB1 in response to inflammatory stimuli. Redox Biol. 2019;24:101203.
Labrador JP, et al. The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep. 2001;2:446–52.
Landen NX, Li D, Stahle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci. 2016;73:3861–85.
Lee JH, et al. Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1. Sci Rep. 2018;8:4908.
Leitinger B. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2. J Biol Chem. 2003;278:16761–9.
Leitinger B. Transmembrane collagen receptors. Annu Rev Cell Dev Biol. 2011;27:265–90.
Leoni G, Neumann PA, Sumagin R, Denning TL, Nusrat A. Wound repair: role of immune-epithelial interactions. Mucosal Immunol. 2015;8:959–68.
Liu T, et al. HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis. Proc Natl Acad Sci U S A. 2019;116:23254–63.
Marquez J, Olaso E. Role of discoidin domain receptor 2 in wound healing. Histol Histopathol. 2014;29:1355–64.
Masson-Meyers DS, et al. Experimental models and methods for cutaneous wound healing assessment. Int J Exp Pathol. 2020;101:21–37.
Mohan R, et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem. 2002;277:2065–72.
Naito AT, et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell. 2012;149:1298–313.
Nayak A, Ferluga J, Tsolaki AG, Kishore U. The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol Lett. 2010;131:139–50.
Olaso E, et al. Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. J Biol Chem. 2002;277:3606–13.
Olaso E, Lin HC, Wang LH, Friedman SL. Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrix remodeling. Fibrogenesis Tissue Repair. 2011;4:5.
Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221–33.
Pegorin GS, et al. Physico-chemical characterization and tissue healing changes by Hancornia speciosa Gomes latex biomembrane. J Biomed Mater Res B Appl Biomater. 2021;109:938–48.
Reid KB. A collagen-like amino acid sequence in a polypeptide chain of human C1q (a subcomponent of the first component of complement). Biochem J. 1974;141:189–203.
Saby C, et al. Type I collagen aging impairs discoidin domain receptor 2-mediated tumor cell growth suppression. Oncotarget. 2016;7:24908–27.
Shrivastava A, et al. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell. 1997;1:25–34.
Son M, Diamond B. C1q-mediated repression of human monocytes is regulated by leukocyte-associated Ig-like receptor 1 (LAIR-1). Mol Med. 2015;20:559–68.
Son M, Santiago-Schwarz F, Al-Abed Y, Diamond B. C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proc Natl Acad Sci U S A. 2012;109:E3160-3167.
Son M, Diamond B, Santiago-Schwarz F. Fundamental role of C1q in autoimmunity and inflammation. Immunol Res. 2015;63:101–6.
Son M, et al. C1q and HMGB1 reciprocally regulate human macrophage polarization. Blood. 2016;128:2218–28.
Son M, et al. Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression. Sci Rep. 2017;7:270.
Sun X, et al. A highly specific graphene platform for sensing collagen triple helix. J Mater Chem B. 2016;4:1064–9.
Sunk IG, et al. Increased expression of discoidin domain receptor 2 is linked to the degree of cartilage damage in human knee joints: a potential role in osteoarthritis pathogenesis. Arthritis Rheum. 2007;56:3685–92.
Thielens NM, Tedesco F, Bohlson SS, Gaboriaud C, Tenner AJ. C1q: a fresh look upon an old molecule. Mol Immunol. 2017;89:73–83.
Thomas HC. Checklist for factors affecting wound healing. Adv Skin Wound Care. 2011;24:192.
Trinder PK, Maeurer MJ, Brackertz D, Loos M. The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis. Immunology. 1996;87:355–61.
Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009;37:1528–42.
Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell. 1997;1:13–23.
Yan Z, et al. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein. Biochim Biophys Acta. 2014;1842:1350–63.
Yu SM, Kim SJ. Salinomycin causes migration and invasion of human fibrosarcoma cells by inducing MMP-2 expression via PI3-kinase, ERK-1/2 and p38 kinase pathways. Int J Oncol. 2016;48:2686–92.
We thank Travis Peng for his technical assistance.
This work was supported by grants from the National Research Foundation of Korea (NRF) Grant funded by the Korean government (MEST) (2017R1A2B3006704 and 2019R1A6A1A03032869 [J.S.S], 2021R1I1A1A01044809 [M.S.K]) and the NIH/National Institute of Allergy and Infectious Diseases (R01AI135063 [M.S.]).
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hayuningtyas, R.A., Han, M., Choi, S. et al. The collagen structure of C1q induces wound healing by engaging discoidin domain receptor 2. Mol Med 27, 125 (2021). https://doi.org/10.1186/s10020-021-00388-y
- Wound healing